Innovations in Relapsed Refractory Multiple Myeloma Care: Debating the Future of Treatment Strategies
16 May 2025 | Program: 16:20—17:50
Chair
Xavier Leleu, MD, PhD
Speaker
Doris Hansen, MD
Speaker
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD
Speaker
Paula Rodríguez-Otero, MD, PhD
| AGENDA | |
|---|---|
| 16:20—16:30 | Welcome and Overview Highlight Key Issues for Debate in the RRMM Space Xavier Leleu, MD, PhD (Chair) Poitiers University Hospital Poitiers, France |
| 16:30—17:00 | Debating the Optimal T-Cell Redirecting Approach: CAR T-Cell Therapies vs Bispecific Antibodies (BsAbs) Doris Hansen, MD Moffitt Cancer Center Tampa, Florida, USA Paula Rodríguez-Otero, MD, PhD University Clinic of Navarra Pamplona, Spain Followed by Faculty Roundtable Discussion |
| 17:00—17:30 | Early RRMM Treatment Landscape: Are There Still Unmet Needs? Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD Oxford University Hospitals Oxford, England Paula Rodríguez-Otero, MD, PhD University Clinic of Navarra Pamplona, Spain Followed by Faculty Roundtable Discussion |
| 17:30—17:40 | New Treatments on the Horizon Xavier Leleu, MD, PhD (Chair) Poitiers University Hospital Poitiers, France |
| 17:40—17:50 | Q&A Xavier Leleu, MD, PhD (Chair) Doris Hansen, MD Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD Paula Rodríguez-Otero, MD, PhD |
